Overview

N-acetyl Cysteine and Patients With Non-alcoholic Fatty Liver Disease

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Effect of N-acetyl cysteine on markers of oxidative stress and insulin resistance in patients with Non-alcoholic fatty liver disease
Phase:
Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Acetylcysteine
N-monoacetylcystine